Most people who get their cholesterol checked never learn about lipoprotein(a). The particle does not appear on a standard ...

Multinational Real-world Data Reinforce Favorable Clinical Profile and Long-Term Safety SOUTH SAN FRANCISCO, Calif., May 11, 2026 (GLOBE ...

Key market opportunities lie in developing IL-6 inhibitors for underexplored indications like atherosclerotic cardiovascular disease and thyroid eye disease. The IL-6 targeted therapy market gains ...

A meta-analysis of 32 studies and 43,618 adults presented at the European Congress on Obesity in Istanbul, Turkey (May 12–15) ...

The chance of developing cognitive impairment was significantly higher for people who have had a heart attack, according to a ...

When researchers pooled data from six major clinical trials of semaglutide, the drug behind Ozempic and Wegovy, they found ...

HoneyNaps, an AI-powered sleep healthcare company, announced that it has been selected for the "2026 Global ICT Unicorn ...

The chance of developing cognitive impairment was significantly higher for people who have had a heart attack, according to a ...

The chance of developing cognitive impairment was significantly higher for people who have had a heart attack, according to a ...

(Nasdaq: ALNY), the leading RNAi therapeutics company, today announced new analyses from the HELIOS-B Phase 3 study of vutrisiran in patients with the cardiomyopathy of wild-type or hereditary ...

Tetsuko Kuroyanagi, whose work as a UNICEF Goodwill Ambassador has taken her to conflict zones around the world for nearly ...

People who survived a heart attack had 5% higher odds each year of developing cognitive impairment compared to people who have not ...